Rosetta Licenses the Rosetta Resolver System to the FGCZ
News Nov 22, 2005
Rosetta Biosoftware has announced that the Functional Genomics Center of Zurich, Switzerland (FGCZ) licensed the Rosetta Resolver system.
The FGCZ will use the Resolver system to analyze and store cross-platform microarray data generated from the hundreds of regional functional genomic projects supported by the expert institution.
"Rosetta Biosoftware is pleased to provide the FGCZ with a flexible and integrated informatics solution that will guarantee consistency and quality for their gene expression research," said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.
"The Resolver system provides advanced tools for raw and analytical gene expression data management."
"The cross-species and cross-platform analysis tools in the system will help the FGCZ advance their research in transcriptomics."
"We are pleased to add the Resolver system to our strong portfolio of analytical resources for conducting genome-wide, high-resolution gene expression analysis," said Dr. Ralph Schlapbach, managing director of the FGCZ.
"The central database and standardized statistical tools will enable all our users to efficiently analyze microarray data for differential expression."
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.